Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram challenge during free fatty acid infusion to assess serotonergic responsivity
NL-OMON33757Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Apr 2009
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Single-arm trial of citalopram and heparin, sponsored by Amsterdam University Medical Center. Primary endpoint: Prolactin response. Planned start Apr 2009; status: not yet recruiting.
02
Drugs
citalopramheparin
Beyond the preview
Go deeper on NL-OMON33757.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON33757.